Roger Stupp

Dr. Roger Stupp is Chief of Neuro-Oncology in the Department of Neurology and Neurological Surgery at Northwestern University Feinberg School of Medicine and Co-Director of the Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital in Chicago, Illinois.

As Associate Director of Strategic Initiatives, he is instrumental in the development and oversight of Lurie Cancer Center’s strategic scientific initiatives applying advanced technologies and collaborative approaches to accelerate and widen the scope of clinical research.

Dr. Stupp’s clinical interests include the multimodality management of primary and secondary brain tumors, head and neck tumors, and lung cancers, as well as new drug development and the association of chemotherapy and radiation therapy.

Dr. Stupp’s work has repeatedly led to the establishment of a new standard of care for newly diagnosed glioblastoma, namely, he was instrumental in developing and establishing the combination of temozolomide and radiotherapy, and more recently, for the clinical development of Tumor Treating Fields in brain tumors.